The Gut Microbiome and Its Impact on Mood and Decision-Making: A Mechanistic and Therapeutic Review
Nutrients · 2025
DOI: 10.3390/nu17213350 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2025. Verfasst von Pierluigi Diotaiuti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Sciences, Society and Health, University of Cassino and Southern Lazio, 03043 Cassino, Italy. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Affect, Decision Making. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 236 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Project ECS0000024 "Ecosistema dell'innovazione-Rome Technopole" financed by EU NextGeneration EU plan.
Abstract (Originalsprache)
Background/Objectives: The gut microbiome is increasingly recognized as a key modulator of central nervous system function through the gut–brain axis. Dysbiosis has been associated with neuropsychiatric disorders such as depression, anxiety, impulsivity, cognitive decline, and addiction. This review aims to synthesize mechanistic insights and therapeutic perspectives on how gut microbiota influence mood regulation, decision-making, and cognitive processes.
Methods
A comprehensive narrative review was conducted using peer-reviewed articles retrieved from PubMed, Scopus, and Web of Science up to August 2025. Studies were included if they explored microbiota-related effects on behavior, mood, cognition, or decision-making using human or animal models. Emphasis was placed on molecular mechanisms, microbiome-targeted therapies, and multi-omics approaches.
Results
Evidence indicates that gut microbiota modulate neurochemical pathways involving serotonin, dopamine, GABA, and glutamate, as well as immune and endocrine axes. Microbial imbalance contributes to low-grade systemic inflammation, impaired neuroplasticity, and altered stress responses, all of which are linked to mood and cognitive disturbances. Specific microbial taxa, dietary patterns, and interventions such as probiotics, prebiotics, psychobiotics, and fecal microbiota transplantation (FMT) have shown promise in modulating these outcomes. The review highlights methodological advances including germ-free models, metagenomic profiling, and neuroimaging studies that clarify causal pathways.
Conclusions
Gut microbiota play a foundational role in shaping emotional and cognitive functions through complex neuroimmune and neuroendocrine mechanisms. Microbiome-based interventions represent a promising frontier in neuropsychiatric care, although further translational research is needed to define optimal therapeutic strategies and address individual variability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Sciences, Society and Health, University of Cassino and Southern Lazio, 03043 Cassino, Italy.
ORCID-Profile: Pierluigi Diotaiuti, Francesco Misiti, Giulio Marotta, Lavinia Falese, Giovanna Elisa Calabrò, Stefania Mancone
Förderung
- Project ECS0000024 "Ecosistema dell'innovazione-Rome Technopole" financed by EU NextGeneration EU plan
Zitieren
APA
Diotaiuti, P., Misiti, F., Marotta, G., Falese, L., Calabrò, G. E., & Mancone, S. (2025). The Gut Microbiome and Its Impact on Mood and Decision-Making: A Mechanistic and Therapeutic Review. Nutrients. https://doi.org/10.3390/nu17213350
Vancouver
Diotaiuti P, Misiti F, Marotta G, Falese L, Calabrò GE, Mancone S. The Gut Microbiome and Its Impact on Mood and Decision-Making: A Mechanistic and Therapeutic Review. Nutrients. 2025. doi:10.3390/nu17213350
BibTeX
@article{Diotaiuti2025,
author = {Diotaiuti, Pierluigi and Misiti, Francesco and Marotta, Giulio and Falese, Lavinia and Calabrò, Giovanna Elisa and Mancone, Stefania},
title = {The Gut Microbiome and Its Impact on Mood and Decision-Making: A Mechanistic and Therapeutic Review},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17213350}
}
EUVIMED